 SAN DIEGO, Dec. 5, 2020 PRNewswire -- Poseida Therapeutics, Inc. NASDAQ:PSTX, a clinical-stage biopharmaceutical company utilizing proprietary gene engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today reported results of an ongoing... 